PNC Financial Services Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Sell |
1,749
-3,920
| -69% | -$409K | ﹤0.01% | 2273 |
|
|
2025
Q1 | $661K | Buy |
5,669
+330
| +6% | +$38.5K | ﹤0.01% | 1355 |
|
|
2024
Q4 | $452K | Sell |
5,339
-90
| -2% | -$7.62K | ﹤0.01% | 1615 |
|
|
2024
Q3 | $488K | Buy |
5,429
+66
| +1% | +$5.93K | ﹤0.01% | 1549 |
|
|
2024
Q2 | $432K | Sell |
5,363
-22
| -0.4% | -$1.77K | ﹤0.01% | 1582 |
|
|
2024
Q1 | $430K | Buy |
5,385
+51
| +1% | +$4.07K | ﹤0.01% | 1632 |
|
|
2023
Q4 | $425K | Sell |
5,334
-17
| -0.3% | -$1.35K | ﹤0.01% | 1627 |
|
|
2023
Q3 | $374K | Sell |
5,351
-176
| -3% | -$12.3K | ﹤0.01% | 1679 |
|
|
2023
Q2 | $397K | Buy |
5,527
+135
| +3% | +$9.7K | ﹤0.01% | 1730 |
|
|
2023
Q1 | $333K | Sell |
5,392
-103
| -2% | -$6.35K | ﹤0.01% | 1805 |
|
|
2022
Q4 | $424K | Sell |
5,495
-105
| -2% | -$8.1K | ﹤0.01% | 1637 |
|
|
2022
Q3 | $250K | Sell |
5,600
-15,687
| -74% | -$700K | ﹤0.01% | 1941 |
|
|
2022
Q2 | $815K | Buy |
21,287
+35
| +0.2% | +$1.34K | ﹤0.01% | 1262 |
|
|
2022
Q1 | $879K | Sell |
21,252
-1
| -0% | -$41 | ﹤0.01% | 1310 |
|
|
2021
Q4 | $802K | Sell |
21,253
-42
| -0.2% | -$1.59K | ﹤0.01% | 1407 |
|
|
2021
Q3 | $703K | Buy |
21,295
+35
| +0.2% | +$1.16K | ﹤0.01% | 1410 |
|
|
2021
Q2 | $1.44M | Buy |
21,260
+32
| +0.2% | +$2.16K | ﹤0.01% | 1046 |
|
|
2021
Q1 | $1.2M | Buy |
21,228
+495
| +2% | +$28K | ﹤0.01% | 1084 |
|
|
2020
Q4 | $1.69M | Hold |
20,733
| – | – | ﹤0.01% | 903 |
|
|
2020
Q3 | $1.48M | Hold |
20,733
| – | – | ﹤0.01% | 884 |
|
|
2020
Q2 | $1.71M | Buy |
20,733
+19,733
| +1,973% | +$1.62M | ﹤0.01% | 832 |
|
|
2020
Q1 | $58K | Hold |
1,000
| – | – | ﹤0.01% | 2534 |
|
|
2019
Q4 | $104K | Buy |
+1,000
| New | +$104K | ﹤0.01% | 2469 |
|